LORISTA HL 100 mg/12,5 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorista hl 100 mg/12,5 mg

krka, d.d., novo mesto - slovenia - combinatii (losartanum+hydrochlorothiazidum) - compr. film. - 100mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic

LORISTA 12,5 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorista 12,5 mg

krka, d.d., novo mesto - slovenia - losartanum - compr. film. - 12,5mg - antagonisti de angiotensina ii antagonisti de angiotensina ii

LORISTA 100 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorista 100 mg

krka, d.d., novo mesto - slovenia - losartanum - compr. film. - 100mg - antagonisti de angiotensina ii antagonisti de angiotensina ii

LORISTA 25 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorista 25 mg

krka, d.d., novo mesto - slovenia - losartanum - compr. film. - 25mg - antagonisti de angiotensina ii antagonisti de angiotensina ii

LORISTA 50 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorista 50 mg

krka, d.d., novo mesto - slovenia - losartanum - compr. film. - 50mg - antagonisti de angiotensina ii antagonisti de angiotensina ii

LORISTA HD 100mg/25mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lorista hd 100mg/25mg

krka, d.d., novo mesto - slovenia - combinatii (losartanum+hydrochlorothiazidum) - compr. film. - 100mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii si diuretice

PANANGIN FORTE 316 mg/280 mg Romania - Tiếng Romania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

panangin forte 316 mg/280 mg

gedeon richter plc. - ungaria - combinatii - compr. film. - 316mg/280mg - potasium (kalium) medicamente cu potasiu

Comirnaty Liên Minh Châu Âu - Tiếng Romania - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Mixtard 30 HM Penfill suspensie injectabila in cartus 100 UI/ml Moldova - Tiếng Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

mixtard 30 hm penfill suspensie injectabila in cartus 100 ui/ml

novo nordisk a/s - suspensie injectabila in cartus - 100 ui/ml

Zocardis 30 30 mg comprimate filmate Moldova - Tiếng Romania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zocardis 30 30 mg comprimate filmate

menarini international operations luxembourg sa - zofenoprilum - comprimate filmate - 30 mg